1267912

Wuhan Biocause Pharmaceutical Development Co., Ltd. — FEI 3004202226

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 14, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wuhan (China)